If confirmed by the Senate, Heidi Overton—officially revealed Wednesday as President Donald Trump’s choice for FDA ...

Looking for a biopharma job in New Jersey? Job postings in the area have increased year over year, according to BioSpace data ...

Melanoma was slower to recur in patients receiving Merck and Moderna's mRNA vaccine with Keytruda, supporting use of the ...

If Heidi Overton clears the Senate nomination process, analysts say she will have a tough job ahead to “restore ...

Touting an “exceptional” gastrointestinal safety profile for its oral obesity drug candidate in a study of healthy volunteers ...

Amylyx shares good news for its investigational GLP-1 blocker; Definium announces positive data for its LSD-based therapy in ...

The FDA’s August approval of Takeda’s Orzeyful for treating the full set of narcolepsy symptoms initiated a new era in the ...

Despite coming away with an early victory over Eli Lilly in the oral obesity face-off, analysts don’t expect Novo Nordisk’s ...

Massachusetts-based biotech accelerator LabCentral signed an agreement with Hong Kong Science and Technology Parks ...

This is the third recent acquisition conducted by Denmark’s LEO Pharma in medical dermatology, a portfolio that marked 12% growth in the first half of the year.

EyePoint’s quest to reduce treatment burden for patients with age-related macular degeneration has hit a bump in the road, with a clinical miss driving the biotech’s stock down by 70%. EyePoint’s late ...

Ivonescimab notched its third approval in China last week, but the label update has tempered expectations for the Summit Therapeutics/Akeso drug, showing that progression-free survival declines over ...